Log in to save to my catalogue

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide front...

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide front...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c0ed08d6cfbb4693a30e7ef32479a601

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

About this item

Full title

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2022-11, Vol.22 (1), p.1224-1224, Article 1224

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Alternative Titles

Full title

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c0ed08d6cfbb4693a30e7ef32479a601

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c0ed08d6cfbb4693a30e7ef32479a601

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-022-10335-7

How to access this item